Diabetes is a leading cause of morbidity and death in the United States. Obesity is a major risk factor for the? most common form of diabetes, type 2 diabetes, which is characterized by resistance to the actions of? insulin. We have discovered a novel, secreted protein called resistin that is adipocyte-specific and circulates? at elevated levels in obesity. Hyperresistinemia impairs glucose tolerance, and lack of resistin improves? hyperglycemia and insulin resistance in mice with diet induced obesity. We hypothesize that 1) resistin will? alter insulin action and cardiovascular disease in genetic models of obesity and atherosclerosis; 2) cellular? actions of resistin involve induction of SOCS-3 and/or inhibition of AMPK, mediated by discrete biochemical? forms of resistin; and 3) that the effects of mouse resistin are translatable to the human. These hypotheses? will be directly tested in the experiments proposed in this project.
Specific Aim 1 is to determine the? effects of resistin deficiency in genetic models of obesity and atherosclerosis. We hypothesize that? mice lacking resistin will be protected from obesity-associated diabetes and atherosclerosis, and will test this? by crossing resistin knockout mice with leptin-deficient ob/ob mice and LDL-receptor null mice, respectively.? Specific Aim 2 is to understand the molecular and cellular determinants of resistin signaling. We will? systematically test the importance of resistin dimerization in a variety of cell types, focusing on potential? mechanisms by which resistin influences glucose metabolism that were cellular assays in different cell types,? focusing on the inhibition of AMPK, as well as the activation of SOCS-3 in several cell types.
Specific Aim 3 ? is to derive and characterize humanized mouse models of resistin expression and physiology. One of? the major questions about resistin concerns the translation of the insights from mouse models to humans.? Mouse resistin is derived exclusively from adipose tissue, whereas macrophages are a major source of? resistin in humans. Preliminary data suggest that human and mouse resistin signal similarly in mouse cells.? Human resistin will be expressed in transgenic mice from a liver specific-transgene as well as the human? promoter which, in humans, expresses resistin primarily in macrophages. These studies will test the? hypothesis that human resistin functions in the mouse, and will provide novel in vivo systems to determine? whether human resistin is a potential mediator of insulin resistance. Together, the proposed studies will? address critical questions about the role of resistin as a link between obesity, insulin resistance, and? diabetes, and a potential target for intervention in these devastating diseases. These studies have important? implications for our society in which diabetes and obesity are rampant.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
5P01DK049210-12
Application #
7486267
Study Section
Special Emphasis Panel (ZDK1)
Project Start
2007-09-01
Project End
2011-08-31
Budget Start
2007-09-01
Budget End
2008-08-31
Support Year
12
Fiscal Year
2007
Total Cost
$305,540
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Juliana, Christine A; Yang, Juxiang; Cannon, Corey E et al. (2018) A PDX1-ATF transcriptional complex governs ? cell survival during stress. Mol Metab 17:39-48
Barnoud, Thibaut; Budina-Kolomets, Anna; Basu, Subhasree et al. (2018) Tailoring Chemotherapy for the African-Centric S47 Variant of TP53. Cancer Res 78:5694-5705
Kim, Yong Hoon; Marhon, Sajid A; Zhang, Yuxiang et al. (2018) Rev-erb? dynamically modulates chromatin looping to control circadian gene transcription. Science 359:1274-1277
Plikus, Maksim V; Guerrero-Juarez, Christian F; Ito, Mayumi et al. (2017) Regeneration of fat cells from myofibroblasts during wound healing. Science 355:748-752
Juliana, Christine A; Yang, Juxiang; Rozo, Andrea V et al. (2017) ATF5 regulates ?-cell survival during stress. Proc Natl Acad Sci U S A 114:1341-1346
Ediger, Benjamin N; Lim, Hee-Woong; Juliana, Christine et al. (2017) LIM domain-binding 1 maintains the terminally differentiated state of pancreatic ? cells. J Clin Invest 127:215-229
Jang, Jessica C; Li, Jiang; Gambini, Luca et al. (2017) Human resistin protects against endotoxic shock by blocking LPS-TLR4 interaction. Proc Natl Acad Sci U S A 114:E10399-E10408
Carr, Rotonya M; Dhir, Ravindra; Mahadev, Kalyankar et al. (2017) Perilipin Staining Distinguishes Between Steatosis and Nonalcoholic Steatohepatitis in Adults and Children. Clin Gastroenterol Hepatol 15:145-147
Park, Hyeong Kyu; Kwak, Mi Kyung; Kim, Hye Jeong et al. (2017) Linking resistin, inflammation, and cardiometabolic diseases. Korean J Intern Med 32:239-247
Ackermann, Amanda M; Zhang, Jia; Heller, Aryel et al. (2017) High-fidelity Glucagon-CreER mouse line generated by CRISPR-Cas9 assisted gene targeting. Mol Metab 6:236-244

Showing the most recent 10 out of 220 publications